ALEXANDRIA, Va., Feb. 25 -- Boston Medical Center, Boston, has been assigned a patent (9,572,879) developed by three co-inventors for "ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2." The co-inventors are Weining Lu, West Roxbury, Massachusetts, Xueping Fan, Braintree, Massachusetts, and David J. Salant, Newton, Massachusetts.

The patent application was filed on Jan. 4, 2013 (14/369,094). The full-text of the patent can be found at http://patf . . .